DONATE TODAY
To Increase Patient Access

Ready to Educate and Recruit Patients for Your Trial or Solution?

Partner with The End Brain Cancer Initiative (EBCI) — only if you're ready to activate.
READ OUR TESTIMONIALS

Who We Are A Fit For

We partner exclusively with companies who are actively enrolling or seeking qualified patients for trials, diagnostics, and device solutions.

We offer:
  • Patient education through trusted national platforms
  • Pre-qualification and referrals
  • Outreach via digital, media, and clinical networks
  • Data sourcing strategies for real-world evidence
Download Our Partnership Brochure

Who We Are Not A Fit For

Our time and resources are dedicated to initiatives ready to make an impact right now.
  • Early-stage companies still in research or pre-clinical phase

  • Programs not yet recruiting or ready for public promotion

Please complete this form to help us determine alignment with EBCI’s Corporate Partnership Program. This program is designed for companies seeking assistance with patient education, clinical trial recruitment, pre-qualification, and digital outreach related to trials, diagnostics, and treatment solutions for brain cancer.
Start Your Partnership Application
*We’ll review your information and reach out to schedule a discovery call if your program is a potential fit.

Meet Some of Our Partners...

Gamma Tile Official Logo - 2024

What Our Partners Say

We are grateful for the support of our corporate partners. Here’s what they have to say about working with the 
End Brain Cancer Initiative.
"Any organization seeking to improve clinical trial engagement, accelerate recruitment, and strengthen
patient partnerships will find in EBCI a trusted, high-impact collaborator."

Wendy Poage

VP, Patient Office
READ MORE
"EBCI’s dedication to understanding and addressing the unmet needs of the PCNSL community, combined with their strategic engagement in clinical research and advocacy, makes them an invaluable partner in the pursuit of better outcomes and quality of life for all those impacted by brain cancer."

Dr. Thomas Lechner, MSc, PhD

VP, Medical Affairs
READ MORE
Coming Soon!
READ MORE

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram